miércoles, 30 de octubre de 2024

FDA Guidance Outlines a Framework for the Evaluation of Long-Term Neurodevelopmental Safety Studies in Neonatal Product Development By Mark A. Tobolowsky —

https://www.thefdalawblog.com/2024/10/fda-guidance-outlines-a-framework-for-the-evaluation-of-long-term-neurodevelopmental-safety-studies-in-neonatal-product-development/?utm_source=rss&utm_medium=rss&utm_campaign=fda-guidance-outlines-a-framework-for-the-evaluation-of-long-term-neurodevelopmental-safety-studies-in-neonatal-product-development

No hay comentarios: